Lab Automation and Robotics Market Size & Share 2026-2035

Lab Automation and Robotics Market Size

The global lab automation and robotics market was valued at USD 7.2 billion in 2025 and is projected to grow from USD 7.5 billion in 2026 to USD 13.7 billion by 2035, expanding at a CAGR of 6.9%, according to the latest report published by Global Market Insights Inc. This substantial growth is driven by several key factors, including increasing adoption in drug discovery and development, increasing need for optimizing clinical workflow, and rising investment in healthcare infrastructure.

The market comprises technologies and systems designed to automate laboratory processes, including sample handling, liquid dispensing, storage, testing, data management, and workflow coordination. These solutions utilize robotics, automation hardware, software, and informatics platforms to improve laboratory efficiency, accuracy, throughput, and operational consistency across pharmaceutical, biotechnology, clinical diagnostics, and research environments.

Leading companies in the market include Thermo Fisher Scientific Inc., Danaher Corporation, Tecan Group Ltd., Hamilton Company, and Agilent Technologies, Inc. These companies are strengthening their market presence through continuous innovation in laboratory robotics, automated liquid handling systems, sample management technologies, laboratory workflow automation, and laboratory informatics solutions. Furthermore, they are focused on enhancing laboratory efficiency, improving workflow accuracy, increasing throughput, and supporting advanced research and diagnostic capabilities through integrated automation platforms and intelligent laboratory technologies.

The market has increased from USD 6.3 billion in 2022 and reached USD 6.8 billion in 2024, with a historic growth rate of 8.5%. Rising investment in healthcare infrastructure is a significant driver of growth in the market, as healthcare providers, research institutes, and diagnostic laboratories increasingly modernize their facilities to meet the growing demand for efficient and accurate healthcare services. Governments and private organizations worldwide are allocating substantial funds toward the expansion of hospitals, clinical laboratories, biotechnology research centers, and pharmaceutical manufacturing facilities, creating a favorable environment for the adoption of automated laboratory solutions.

These investments support the integration of robotics, automated sample handling systems, laboratory information management systems (LIMS), and advanced diagnostic platforms that improve productivity, reduce human error, and enhance testing capacity. For instance, according to the National Institutes of Health (NIH), the Indian government spent approximately 2% of the country's GDP on healthcare in FY 2022 and projected this figure to surpass 2.5% by 2025. Additionally, around INR 860 billion was allocated to the Ministry of Health and Family Welfare in the FY 2022 Union Budget. Furthermore, India's health-tech sector attracted nearly USD 1.74 billion in private equity and venture capital investments in 2021. Such substantial investments in healthcare and life sciences infrastructure are accelerating the deployment of laboratory automation and robotic technologies, thereby driving market expansion globally.

Additionally, The increasing need for optimizing clinical workflow is a key driver of the market. Healthcare facilities, diagnostic laboratories, and research institutions are experiencing a growing volume of patient samples, complex testing procedures, and stringent turnaround time requirements. As a result, laboratories are increasingly adopting automation and robotic technologies to streamline operations, improve efficiency, and ensure consistent test quality. Automated systems can perform repetitive tasks such as sample preparation, handling, sorting, analysis, and data management with minimal human intervention, enabling laboratory personnel to focus on higher-value activities.

Moreover, the rising prevalence of chronic diseases, growing demand for precision medicine, and expansion of diagnostic testing are placing considerable pressure on laboratory workflows. Lab automation solutions help address these challenges by reducing manual errors, minimizing sample contamination risks, enhancing throughput, and accelerating result delivery. Robotics and advanced software platforms also facilitate seamless integration of laboratory processes, improving resource utilization and operational productivity. As healthcare organizations continue to prioritize workflow optimization to enhance patient outcomes and reduce operational costs, demand for laboratory automation and robotics solutions is expected to increase significantly, supporting sustained market growth.

Lab Automation and Robotics Market Trends

• The rising volume of clinical diagnostic testing is a major driver of the market. Increasing prevalence of chronic diseases, infectious diseases, and age-related health conditions has significantly increased the number of laboratory tests performed globally. Laboratories are consequently under pressure to process large sample volumes while maintaining high levels of accuracy and efficiency.
• Additionally, growing awareness of preventive healthcare and routine health screening programs has contributed to a surge in diagnostic testing demand. Healthcare providers are increasingly relying on laboratory results for early disease detection, treatment monitoring, and personalized medicine approaches. This expanding testing workload is encouraging laboratories to adopt automated systems that can handle higher throughput with minimal manual intervention.
• Furthermore, advancements in molecular diagnostics, genetic testing, and biomarker-based analyses have increased the complexity of laboratory procedures. Traditional manual workflows often struggle to manage these sophisticated testing requirements efficiently. Lab automation and robotics help streamline sample handling, testing, and data processing, thereby reducing turnaround times and improving overall laboratory productivity.
• Moreover, healthcare organizations are continuously seeking solutions to address workforce shortages, minimize operational errors, and enhance service quality. Automated laboratory platforms enable faster processing of large testing volumes while ensuring consistency and reliability of results. As clinical diagnostic testing continues to grow worldwide, the demand for advanced laboratory automation and robotic solutions is expected to increase substantially, driving market expansion.

 Lab Automation and Robotics Market Analysis

Based on component, the lab automation and robotics market is segmented into hardware, software and informatics, and services. The hardware segment accounted for the largest market share of 63.1% in 2025.

• Hardware forms the foundation of laboratory automation systems, encompassing robotic arms, automated workstations, liquid handling systems, automated storage units, and sample transportation equipment. Growing emphasis on high-throughput testing and error-free laboratory operations is encouraging healthcare and research facilities to invest in advanced automation hardware capable of handling complex workflows with greater efficiency.
• The adoption of automation hardware continues to increase as laboratories seek to improve operational scalability and reduce dependence on manual processes. Continuous advancements in robotics, sensor technologies, and automated sample management systems are enhancing laboratory productivity, enabling institutions to process larger testing volumes while maintaining accuracy and consistency, thereby supporting market growth.
• The software and informatics segment accounted for USD 1.5 billion in 2025 and is projected to expand to a CAGR of 7.4% from 2026 to 2035. Software and informatics solutions are becoming increasingly important as laboratories generate large volumes of complex diagnostic and research data. These platforms enable seamless workflow management, data integration, result validation, and real-time monitoring, helping laboratories improve operational visibility and decision-making capabilities.
• Growing demand for connected laboratory ecosystems is accelerating the adoption of laboratory information management systems (LIMS), analytics platforms, and cloud-based informatics solutions. As laboratories focus on improving data traceability, regulatory compliance, and workflow efficiency, software solutions are playing a crucial role in maximizing the value of automated laboratory infrastructure and driving market expansion.
• The services segment accounted for USD 1.1 billion in 2025 and is projected to expand to a CAGR of 5.4% from 2026 to 2035. The services segment is gaining traction as organizations require specialized support for the implementation, maintenance, validation, and optimization of laboratory automation systems. As automation environments become increasingly sophisticated, laboratories are relying on service providers to ensure smooth deployment and uninterrupted performance of automated platforms.
• Demand for professional services is also increasing due to the need for system customization, user training, software upgrades, and ongoing technical assistance. Furthermore, organizations are prioritizing long-term operational reliability and regulatory compliance, creating sustained demand for service offerings that enhance system efficiency, reduce downtime, and improve overall laboratory performance.

Based on application, the lab automation and robotics market is segmented into drug discovery, genomics, proteomics, clinical diagnostics, and other applications. The drug discovery segment accounted for the largest market share of 32.1% in 2025.

• The drug discovery application remains a key growth area for laboratory automation and robotics as pharmaceutical and biotechnology companies seek to accelerate the identification and evaluation of novel drug candidates. The increasing complexity of therapeutic research, particularly in oncology, rare diseases, and biologics, has intensified the need for automated platforms capable of handling large-scale screening and compound analysis activities.
• Automation technologies are increasingly being integrated into early-stage research workflows to improve experiment reproducibility and shorten development timelines. Robotics-enabled screening systems, automated liquid handling platforms, and AI-supported laboratory tools are helping organizations generate higher-quality data while optimizing research resources, supporting greater adoption across drug development
• The genomics segment accounted for significant revenue in 2025 and is anticipated to grow at a CAGR of 7% over the forecast period. The genomics segment is experiencing strong momentum owing to the growing utilization of sequencing technologies in disease research, precision medicine, and population health studies. The rapid expansion of genomic datasets has created demand for automated solutions that can efficiently manage sample preparation, sequencing workflows, and data processing activities.
• Laboratories are increasingly deploying automation systems to support high-throughput genomic testing while maintaining consistency across complex analytical processes. The integration of robotics with advanced sequencing platforms enables faster turnaround times and scalable operations, making automation an essential component of modern genomics laboratories.
• The proteomics segment accounted for significant revenue in 2025 and is anticipated to grow at a CAGR of 7.6% over the forecast period. Proteomics has emerged as a critical application area as researchers focus on understanding protein structure, function, and interactions to support biomarker discovery and therapeutic development. The intricate nature of proteomic workflows often requires precise sample handling and highly standardized analytical procedures, creating favorable conditions for automation adoption.
• The increasing use of mass spectrometry-based research and protein characterization studies is encouraging laboratories to implement robotic platforms that enhance workflow precision and throughput. Automated systems help researchers manage complex experiments more effectively, improving data quality and enabling deeper biological insights that contribute to market growth.
• The clinical diagnostics segment accounted for significant revenue in 2025 and is anticipated to grow at a CAGR of 6.5% over the forecast period. Clinical diagnostics represents the dominant application segment, supported by the continuous rise in testing requirements across hospitals, diagnostic laboratories, and healthcare networks. Growing demand for accurate, rapid, and large-volume testing has made automation an important operational strategy for clinical laboratories seeking to enhance efficiency while maintaining quality standards.
• The expansion of molecular diagnostics, infectious disease testing, and chronic disease monitoring is accelerating the deployment of robotic laboratory systems across diagnostic settings. Automated analyzers, specimen processing systems, and integrated laboratory workflows are enabling healthcare providers to manage increasing sample volumes more effectively, reinforcing the segment’s leading contribution to overall market growth.

Based on end use, the lab automation and robotics market is segmented into pharmaceutical & biotechnology companies, diagnostic labs, research & academic institutes, contract research organizations (CROs) & contract development and manufacturing organizations (CDMOs), and other end users. The pharmaceutical & biotechnology companies segment accounted for the largest market share of 38.1% in 2025.

• Pharmaceutical and biotechnology companies represent the largest end-user segment owing to their continuous investment in research, drug development, biologics manufacturing, and quality control operations. As development pipelines expand and competition intensifies, organizations are increasingly deploying automated laboratory platforms to accelerate experimental processes and optimize resource utilization.
• The shift toward data-driven drug development and precision therapeutics is further strengthening demand for robotic laboratory systems within this segment. Automation enables companies to improve reproducibility, enhance screening efficiency, and support large-scale research programs, making it a strategic component of modern pharmaceutical and biotechnology operations.
• The diagnostic labs segment accounted for significant revenue in 2025 and is anticipated to grow at a CAGR of 6.8% over the forecast period. Diagnostic laboratories are increasingly adopting laboratory automation to manage rising testing volumes while maintaining operational accuracy and consistency. Growing demand for quick diagnostic outcomes and standardized laboratory procedures is encouraging facilities to modernize their testing infrastructure with automated technologies.
• The expansion of specialized testing services, including molecular diagnostics and advanced pathology testing, is creating additional demand for integrated automation solutions. Automated workflows help laboratories streamline sample processing and improve laboratory throughput, supporting broader adoption across both independent and network-based diagnostic facilities.
• The research and academic institutes segment accounted for significant revenue in 2025 and is anticipated to grow at a CAGR of 6.4% over the forecast period. Research and academic institutes are utilizing laboratory automation to support complex scientific investigations and multidisciplinary research initiatives. As research projects generate larger datasets and require greater experimental precision, institutions are incorporating automated systems to enhance workflow standardization and research efficiency.
• Increasing funding for life sciences research and translational medicine programs is contributing to the adoption of robotic laboratory platforms. Automation allows researchers to conduct high-volume studies with improved consistency, enabling institutions to expand research capabilities while maximizing laboratory productivity.
  

North America Lab Automation and Robotics Market

The North America region accounted for 39% of the market in 2025. The market in North America is experiencing robust expansion.

• The U.S. market was valued at USD 2.3 billion and USD 2.4 million in 2022 and 2023, respectively. The market size reached USD 2.6 billion in 2025, growing from USD 2.5 billion in 2024, and is anticipated to grow at a CAGR of 6.6% from 2026 to 2035.
• North America continues to lead global pharmaceutical innovation, supported by a strong presence of pharmaceutical companies, biotechnology firms, and research institutions. The growing focus on developing novel therapeutics, biologics, and personalized medicines is creating sustained demand for advanced laboratory automation technologies.
• Organizations are increasingly integrating robotics into drug screening, sample preparation, and compound analysis workflows to improve research efficiency. Automation enables faster data generation and supports the management of complex research programs, strengthening market growth across the region.
• Additionally, rising investments in artificial intelligence-driven drug discovery platforms are accelerating the integration of automated laboratory systems. This trend is encouraging broader adoption of robotics solutions throughout pharmaceutical research and development environments.

Europe Lab Automation and Robotics Market

Europe lab automation and robotics industry accounted for USD 1.9 billion in 2025 and is anticipated to show lucrative growth over the forecast period.

• European healthcare systems are placing greater emphasis on operational efficiency as laboratories face increasing diagnostic workloads and resource constraints. This has encouraged healthcare providers to modernize laboratory infrastructure through automation and robotics technologies.
• Stringent quality requirements and a growing focus on standardized laboratory practices are driving the implementation of automated workflow solutions. Laboratories are utilizing robotics to streamline testing procedures, reduce manual interventions, and improve turnaround times.
• Moreover, the expansion of centralized laboratory networks across several European countries is strengthening demand for integrated automation platforms. These solutions support improved workflow coordination and help laboratories manage rising testing volumes more effectively.

Asia Pacific Lab Automation and Robotics Market

The Asia Pacific region is projected to show a lucrative growth of about 7.5% during the forecast period.

• Asia Pacific is witnessing substantial investments in healthcare infrastructure, supported by government initiatives, private sector funding, and expanding healthcare access. The development of new hospitals, diagnostic centers, and research facilities is creating favorable opportunities for laboratory automation providers.
• Furthermore, countries across the region are prioritizing modernization of healthcare systems to enhance diagnostic capabilities and support growing patient populations. This is encouraging the deployment of advanced robotic systems and automated laboratory equipment.
• Additionally, increasing investments in biotechnology, life sciences research, and health technology sectors are fostering the adoption of automation solutions. As healthcare infrastructure continues to evolve, demand for efficient and scalable laboratory operations is expected to strengthen significantly.

Latin America Lab Automation and Robotics Market

The Latin America lab automation and robotics industry is experiencing robust growth over the analysis timeframe.

• The growing burden of chronic and infectious diseases across Latin America is contributing to a steady increase in diagnostic testing requirements. Laboratories are expanding testing capacities to meet rising demand for disease detection, monitoring, and preventive healthcare services.
• Additionally, improving access to healthcare services and greater awareness regarding early diagnosis are generating higher sample volumes across diagnostic facilities. This trend is encouraging laboratories to adopt automated technologies capable of supporting efficient testing workflows.
• Automation solutions are helping diagnostic centers improve productivity while maintaining testing accuracy and consistency. As healthcare providers continue to enhance diagnostic capabilities, the adoption of laboratory robotics is expected to accelerate across the region.

Middle East and Africa Lab Automation and Robotics Market

The Middle East and Africa (MEA) market is experiencing robust growth over the analysis timeframe.

• Countries across the Middle East and Africa are increasingly investing in healthcare modernization programs aimed at strengthening healthcare delivery and diagnostic capabilities. Large-scale healthcare projects and the expansion of specialized medical facilities are creating opportunities for laboratory automation adoption.
• Furthermore, governments are prioritizing healthcare diversification strategies and investing in advanced diagnostic and research infrastructure. These initiatives are encouraging healthcare institutions to implement automated laboratory technologies that enhance operational efficiency and service quality.
• Additionally, the establishment of new diagnostic laboratories, research centers, and healthcare hubs is supporting demand for robotics-enabled laboratory solutions. The growing focus on healthcare quality and technological advancement is expected to contribute significantly to market expansion throughout the region.

Lab Automation and Robotics Market Share

• The top five players, Thermo Fisher Scientific Inc., Danaher Corporation (Beckman Coulter Life Sciences), Tecan Group Ltd., Hamilton Company, and Agilent Technologies, Inc., collectively account for approximately 56% of the global market. Their market leadership is supported by extensive portfolios comprising automated liquid handling systems, robotic laboratory platforms, automated sample management solutions, laboratory workflow automation technologies, and integrated laboratory informatics systems. These companies maintain a strong presence across pharmaceutical and biotechnology companies, clinical diagnostics laboratories, genomics facilities, and research institutions.
• Lab automation and robotics manufacturers, laboratory technology companies, and workflow solution providers are increasingly focusing on innovations that improve laboratory efficiency, accuracy, and productivity. Advancements in automated liquid handling systems, robotic workstations, automated storage systems, collaborative robots, and laboratory informatics platforms are streamlining laboratory operations. Continuous investments in AI-enabled automation and integrated laboratory workflows are accelerating adoption across pharmaceutical companies, diagnostic laboratories, research institutes, and healthcare organizations.
• Market participants are increasingly engaging in strategic collaborations to expand automation capabilities and advance laboratory technologies. Partnerships between automation providers, pharmaceutical companies, diagnostic laboratories, and research institutions are supporting the development of next-generation robotic platforms and high-throughput laboratory systems. Furthermore, collaborations involving AI developers and life sciences organizations are enhancing smart laboratory workflows, improving data management, and driving broader adoption of laboratory automation and robotics solutions worldwide.

Lab Automation and Robotics Market Companies

Few of the prominent players operating in the lab automation and robotics industry include:

• Agilent Technologies, Inc.
• Becton, Dickinson and Company (BD)
• Bio-Rad Laboratories, Inc.
• Danaher Corporation (Beckman Coulter Life Sciences)
• Eppendorf SE
• Hamilton Company
• HighRes Biosolutions
• Hudson Robotics, Inc.
• QIAGEN N.V.
• Revvity, Inc.
• Roche Diagnostics
• Siemens Healthineers AG
• SPT Labtech Ltd.
• Tecan Group Ltd.
• Thermo Fisher Scientific Inc.

• Hamilton company

Hamilton Company is a prominent provider of laboratory automation solutions, helping organizations optimize sample handling processes, improve workflow reproducibility, and support scalable laboratory operations in research and healthcare environments.

• Agilent Technologies

Agilent Technologies, Inc. maintains a strong position in the market through integrated laboratory automation capabilities that enhance analytical workflows, improve data quality, and support efficient laboratory management across diverse applications.

Lab Automation and Robotics Industry News:

• In November 2025, Revvity, Inc. announced the acquisition of ACD/Labs to expand its Signals software capabilities and strengthen its research informatics portfolio. The acquisition enhanced Revvity's ability to deliver integrated scientific software solutions across drug discovery, development, and manufacturing workflows, thereby strengthening its competitive position in the market.

The lab automation and robotics market research report includes an in-depth coverage of the industry with estimates and forecast in terms of revenue in USD Million and from 2022 – 2035 for the following segments:

Click here to Buy Section of this Report

Market, By Component

• Hardware
  • Automated liquid handling systems
  • Robotic arms and collaborative lab robots
  • Automated plate handlers, microplate readers, and washers  
  • Automated storage and retrieval systems
• Software and informatics
  • LIMS (Laboratory Information Management Systems)
  • Other software and informatics
• Services

Market, By Application

• Drug Discovery
• Genomics
• Proteomics
• Clinical diagnostics
• Other applications

Market, By End use

• Pharmaceutical and biotechnology companies
• Diagnostic labs
• Research and academic institutes
• Contract research organizations & contract development manufacturing
• Other end users

The above information is provided for the following regions and countries:

• North America
  • U.S.
  • Canada
• Europe
  • Germany
  • UK
  • France
  • Italy
  • Spain
  • Netherlands
• Asia Pacific
  • China
  • India
  • Japan
  • Australia
  • South Korea
• Latin America
  • Brazil
  • Mexico
  • Argentina
• Middle East and Africa
  • Saudi Arabia
  • South Africa
  • UAE